The first generic drug maker to launch after a patent expires captures up to 90% of the market - and keeps most of it for years. Here’s how the Hatch-Waxman Act creates lasting dominance.
Read MoreTag: generic market share
First-Mover Advantage: How First Generic Drug Makers Dominate the Market
Archive
Categories
How to Use Medicare Extra Help to Pay Less for Generic Prescriptions
Medicare Extra Help cuts generic prescription costs to $4.90 per pill for low-income seniors. Learn who qualifies, how to apply, and why so many miss out - even when they should get it.
Kaposi Sarcoma Prevention: Practical Tips for Reducing Your Risk
Worried about Kaposi sarcoma? This guide breaks down the main ways to lower your risk, with easy-to-follow tips on immune health and lifestyle choices. Learn why certain people are more at risk and what daily habits can make a real difference. Get real-world advice, not medical jargon, to keep you and your loved ones safer. If you or someone you know is worried about this cancer, the info here will actually help.
Inositol Nicotinate: Boost Your Well‑Being with the Modern Dietary Supplement
Discover how inositol nicotinate, a vitamin B complex supplement, enhances mood, metabolism, and overall well‑being for today’s busy lifestyle.
Ischemic vs. Hemorrhagic Stroke: Types, Symptoms, and Prevention Strategies
Stroke types differ in cause and treatment. Ischemic strokes block blood flow (87% of cases), hemorrhagic involve bleeding (13-15%). Knowing the difference is critical for emergency care. Prevention strategies vary: blood pressure control for hemorrhagic, anticoagulants for ischemic. Recognizing FAST signs can save lives.
UK Substitution Laws: How NHS Policies on Generic Medicines and Care Shifts Affect You
UK NHS substitution laws now require pharmacists to use generic medicines unless specified otherwise, and shift care from hospitals to community settings. Learn how these 2025 changes affect your prescriptions, access to care, and what to do if you're struggling with digital-only services.